ADRA1D Antikörper (3rd Cytoplasmic Domain)
Kurzübersicht für ADRA1D Antikörper (3rd Cytoplasmic Domain) (ABIN1731577)
Target
Alle ADRA1D Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- 3rd Cytoplasmic Domain
-
Spezifität
- Reacts with human ADRA1D
-
Kreuzreaktivität (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins.
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- Synthetic 20 amino acid peptide from 3rd cytoplasmic domain of human ADRA1D. Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Monkey (100%), Marmoset (100%), Bovine (100%), Dog (100%), Bat (100%), Panda (100%)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: IHC - P (1 μg/mL - 3
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-80 °C
-
Informationen zur Lagerung
- Long term: -70°C, Short term: +4°C
-
-
- ADRA1D (Adrenergic Receptor, alpha 1d (ADRA1D))
-
Andere Bezeichnung
- ADRA1D
-
Hintergrund
- This alpha-adrenergic receptor mediates its effect through the influx of extracellular calcium.
-
UniProt
- P25100
Target
-